Pharming (PHAR) Intangibles (2018 - 2026)

Pharming (PHAR) has 9 years of Intangibles data on file, last reported at $128.1 million in Q2 2026.

• Quarterly Intangibles fell 5.75% year-over-year to $128.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $128.1 million (down 5.75% YoY) and the FY2025 annual result came in at $135.5 million, up 122.05% from the prior year.
• Intangibles fell to $128.1 million in Q2 2026, from $131.0 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $138.9 million in Q1 2025 to a low of $70123.0 in Q3 2022.
• A 5-year average of $88.3 million and a median of $75.4 million in 2022 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles sank 99.92% — and 2023, when it soared 99509.26%.
• Tracing PHAR's Intangibles over 5 years: stood at $75.1 million in 2022, then slipped by 5.13% to $71.3 million in 2023, then slipped by 14.35% to $61.0 million in 2024, then soared by 122.05% to $135.5 million in 2025, then retreated by 5.5% to $128.1 million in 2026.
• The last three Intangibles figures came in at $128.1 million (Q2 2026), $131.0 million (Q1 2026), and $135.5 million (Q4 2025), per Business Quant data.